CTCXW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, SAVAW, and CELUW
Should you be buying Carmell stock or one of its competitors? The main competitors of Carmell include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.
180 Life Sciences (NASDAQ:ATNFW) and Carmell (NASDAQ:CTCXW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, community ranking, profitability, earnings, institutional ownership and risk.
In the previous week, 180 Life Sciences had 1 more articles in the media than Carmell. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Carmell. Carmell's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
180 Life Sciences and Carmell both received 0 outperform votes by MarketBeat users.
Summary
180 Life Sciences and Carmell tied by winning 1 of the 2 factors compared between the two stocks.
Get Carmell News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTCXW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CTCXW vs. The Competition
Related Companies and Tools
